硼代查尔酮类化合物作为一种新型的抗增殖剂，其结构类似于 combretastatin A-4。
A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent.
机构信息
Department of Oncology, 3970 Reservoir Road, Drug Discovery Program, Georgetown University Medical Center, Washington, DC 20057, United States.
出版信息
Bioorg Med Chem. 2010 Jan 15;18(2):971-7. doi: 10.1016/j.bmc.2009.11.003. Epub 2009 Nov 10.
Abstract
Chalcones represent a class of natural products that inhibits tubulin assembly. In this study we designed and synthesized boronic acid analogs of chalcones in an effort to compare biological activities with combretastatin A-4, a potent inhibitor of tubulin polymerization. Systematic evaluation of the positional effects of the carbonyl moiety towards inhibition of tubulin polymerization, cancer cell proliferation and angiogenesis revealed that placement of the carbonyl adjacent to the trimethoxybenzene A-ring resulted in more active compounds than when the carbonyl group was placed adjacent to the C-ring. Our study identified a boronic acid chalcone with inhibition towards 16 human cancer cell lines in the 10-200nM range, and another three cell lines with GI(50)-values below 10nM. Furthermore, this drug has significant anti-angiogenesis effects demonstrated by HUVEC tube formation and aortic ring assay.
摘要
查耳酮是一类天然产物，能抑制微管蛋白的组装。在这项研究中，我们设计并合成了查耳酮的硼酸类似物，以努力比较其与 combretastatin A-4 的生物学活性，后者是一种有效的微管聚合抑制剂。系统评估羰基在抑制微管蛋白聚合、癌细胞增殖和血管生成方面的位置效应表明，将羰基置于三甲氧基苯 A 环附近的位置会产生比将羰基置于 C 环附近时更具活性的化合物。我们的研究确定了一种硼酸查尔酮，对 16 个人类癌细胞系的抑制作用在 10-200nM 范围内，另外三个细胞系的 GI(50)值低于 10nM。此外，该药物具有显著的抗血管生成作用，表现在 HUVEC 管形成和主动脉环测定中。
相似文献
1
A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent.硼代查尔酮类化合物作为一种新型的抗增殖剂，其结构类似于 combretastatin A-4。
Bioorg Med Chem. 2010 Jan 15;18(2):971-7. doi: 10.1016/j.bmc.2009.11.003. Epub 2009 Nov 10.
2
Synthesis and structure-activity relationship of boronic acid bioisosteres of combretastatin A-4 as anticancer agents.作为抗癌剂的康普瑞他汀A-4硼酸生物电子等排体的合成及构效关系
Bioorg Med Chem. 2024 Dec 15;116:117999. doi: 10.1016/j.bmc.2024.117999. Epub 2024 Nov 10.
3
Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.2-萘基反式二苯乙烯和氰基二苯乙烯作为抗癌剂的合成与评价
Anticancer Agents Med Chem. 2018;18(4):556-564. doi: 10.2174/1871521409666170412115703.
4
A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors.两步法合成康普瑞汀 A-4 及其衍生物作为有效的微管组装抑制剂。
Bioorg Med Chem. 2020 Oct 1;28(19):115684. doi: 10.1016/j.bmc.2020.115684. Epub 2020 Aug 5.
5
Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.新型康普瑞汀 A-4 硫代衍生物的设计、合成及作为微管靶向剂的生物评价。
Eur J Med Chem. 2018 Jan 20;144:797-816. doi: 10.1016/j.ejmech.2017.11.050. Epub 2017 Dec 12.
6
Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.新型咪唑查尔酮衍生物的设计、合成及作为潜在抗癌剂和微管蛋白聚合抑制剂的生物评价。
Bioorg Chem. 2021 Jul;112:104904. doi: 10.1016/j.bioorg.2021.104904. Epub 2021 Apr 20.
7
Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.新型连接桥和 B 环修饰的康普瑞汀 A-4（CA-4）类似物的设计、合成及抗肿瘤活性研究作为有效的微管蛋白抑制剂。
Sci Rep. 2016 May 3;6:25387. doi: 10.1038/srep25387.
8
Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.源自氨基氧杂环丁二烯 A-4 的氨基甲酸酯类化合物作为血管破坏剂的合成及生物学评价
Eur J Med Chem. 2018 Mar 10;147:183-193. doi: 10.1016/j.ejmech.2018.01.058. Epub 2018 Feb 9.
9
Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.评估二苯乙烯、查尔酮和黄烷酮的多功能杂化类似物。
Anticancer Agents Med Chem. 2018 Feb 7;17(14):1915-1923. doi: 10.2174/1871520617666170530091223.
10
Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.构象限制型 β-内酰胺型康普瑞汀类似物的先导化合物鉴定：合成、抗增殖活性和微管蛋白靶向作用。
Eur J Med Chem. 2010 Dec;45(12):5752-66. doi: 10.1016/j.ejmech.2010.09.033. Epub 2010 Sep 22.
引用本文的文献
1
Design and Synthesis of Boronic Chalcones with Dual Anticancer and Anti-Inflammatory Activity.具有双重抗癌和抗炎活性的硼酸查耳酮的设计与合成
Molecules. 2025 Jul 19;30(14):3032. doi: 10.3390/molecules30143032.
2
Ultrasound-Assisted Synthesis of Substituted Chalcone-Linked 1,2,3-Triazole Derivatives as Antiproliferative Agents: In Vitro Antitumor Activity and Molecular Docking Studies.超声辅助合成作为抗增殖剂的取代查尔酮连接的1,2,3-三唑衍生物：体外抗肿瘤活性和分子对接研究
Int J Mol Sci. 2025 Apr 4;26(7):3389. doi: 10.3390/ijms26073389.
3
Synthesis and Evaluation of Boron-Containing Heterocyclic Compounds with Antimicrobial and Anticancer Activities.具有抗菌和抗癌活性的含硼杂环化合物的合成与评价
Molecules. 2025 Feb 28;30(5):1117. doi: 10.3390/molecules30051117.
4
Synthesis and structure-activity relationship of boronic acid bioisosteres of combretastatin A-4 as anticancer agents.作为抗癌剂的康普瑞他汀A-4硼酸生物电子等排体的合成及构效关系
Bioorg Med Chem. 2024 Dec 15;116:117999. doi: 10.1016/j.bmc.2024.117999. Epub 2024 Nov 10.
5
Organohalogen chalcones: design, synthesis, ADMET prediction, molecular dynamics study and inhibition effect on acetylcholinesterase and carbonic anhydrase.有机卤代查尔酮：设计、合成、ADMET预测、分子动力学研究以及对乙酰胆碱酯酶和碳酸酐酶的抑制作用
Mol Divers. 2024 Dec;28(6):3739-3755. doi: 10.1007/s11030-023-10774-9. Epub 2024 Jan 3.
6
Research Progress on Structural Modification of Effective Antitumor Active Ingredients in Licorice.甘草中有效抗肿瘤活性成分的结构修饰研究进展。
Molecules. 2023 Aug 3;28(15):5855. doi: 10.3390/molecules28155855.
7
Novel chalcone-derived pyrazoles as potential therapeutic agents for the treatment of non-small cell lung cancer.新型查尔酮衍生吡唑类化合物作为治疗非小细胞肺癌的潜在治疗剂。
Sci Rep. 2022 Mar 8;12(1):3703. doi: 10.1038/s41598-022-07691-6.
8
A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.综述：合成查耳酮衍生物作为微管蛋白聚合抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):9-38. doi: 10.1080/14756366.2021.1976772.
9
Chalcone Derivatives: Role in Anticancer Therapy.查尔酮衍生物：在抗癌治疗中的作用。
Biomolecules. 2021 Jun 16;11(6):894. doi: 10.3390/biom11060894.
10
Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications.硼酸及其衍生物在药物化学中的应用：合成与生物应用。
Molecules. 2020 Sep 21;25(18):4323. doi: 10.3390/molecules25184323.
本文引用的文献
1
Chalcone-analogue fluorescent prfobes for saccharides signaling using the boronic acid group.用于糖类信号传导的含硼酸基团的查尔酮类似物荧光探针。
Tetrahedron Lett. 2002 Apr 1;43(14):2615-2618. doi: 10.1016/s0040-4039(02)00312-x. Epub 2002 Mar 6.
2
Structure-based discovery of a boronic acid bioisostere of combretastatin A-4.基于结构的柯里拉京A-4硼酸生物电子等排体的发现。
Chem Biol. 2005 Sep;12(9):1007-14. doi: 10.1016/j.chembiol.2005.06.016.
3
Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.黄烷卡瓦因A是一种从卡瓦提取物中分离出的新型查尔酮，它通过参与依赖Bax蛋白和线粒体的凋亡途径诱导膀胱癌细胞凋亡，并抑制小鼠肿瘤生长。
Cancer Res. 2005 Apr 15;65(8):3479-86. doi: 10.1158/0008-5472.CAN-04-3803.
4
Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents.合成查耳酮作为潜在的抗炎和癌症化学预防剂。
Eur J Med Chem. 2005 Jan;40(1):103-12. doi: 10.1016/j.ejmech.2004.09.006.
5
Antibacterial chalcones--bioisosteric replacement of the 4'-hydroxy group.抗菌查耳酮——4'-羟基的生物电子等排体取代
Bioorg Med Chem. 2004 Jun 1;12(11):3047-54. doi: 10.1016/j.bmc.2004.03.071.
6
Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.新型硼酸查耳酮衍生物作为抗肿瘤剂的设计、合成与评价
J Med Chem. 2003 Jul 3;46(14):2813-5. doi: 10.1021/jm030213+.
7
Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.他卡醇内酯E和A：具有微管稳定活性的植物源甾体。
Cancer Res. 2003 Jun 15;63(12):3211-20.
8
Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.通过定量比较抗有丝分裂剂对纯化微管蛋白聚合作用的影响来对其进行评估。
Cell Biochem Biophys. 2003;38(1):1-22. doi: 10.1385/CBB:38:1:1.
9
Potent antimitotic and cell growth inhibitory properties of substituted chalcones.取代查耳酮的强效抗有丝分裂和细胞生长抑制特性。
Bioorg Med Chem Lett. 1998 May 5;8(9):1051-6. doi: 10.1016/s0960-894x(98)00162-0.
10
Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.强效秋水仙碱位点抗有丝分裂剂curacin A与微管蛋白相互作用的构效关系分析及其类似物对MCF-7乳腺癌细胞生长的影响。
Mol Pharmacol. 1998 Jan;53(1):62-76. doi: 10.1124/mol.53.1.62.
Zotero 插件